Myasthenia gravis (MG) can be triggered or worsened by a surprisingly wide range of factors, from common medications and infections to surgery, hormonal shifts, and even hot weather. The condition involves the immune system producing antibodies that attack the connection between nerves and muscles, blocking signals that tell muscles to contract. Understanding what sets off this process, or makes it flare, helps you avoid preventable episodes of worsening weakness.
How the Immune Attack Works
In most people with MG, the immune system produces antibodies that bind to acetylcholine receptors on muscle cells. Acetylcholine is the chemical messenger that carries signals from nerves to muscles. When antibodies latch onto these receptors, they cause the receptors to break down, get pulled inside the cell, or simply stop working. The result is that nerve signals don’t reach the muscle properly, leading to weakness that worsens with repeated use and improves with rest.
Research using RNA sequencing on human muscle cells shows that this antibody binding doesn’t just block signals. It actively changes how more than 400 genes behave inside muscle cells, disrupting processes related to cholesterol metabolism, the structural scaffolding of cells, and muscle contraction itself. This means the damage goes deeper than a simple blockade.
The Thymus Gland Connection
The thymus, a small gland behind the breastbone that trains immune cells, is abnormal in roughly 80% of people who test positive for acetylcholine receptor antibodies. In some cases, the thymus is enlarged with excess immune tissue. In others, a tumor called a thymoma develops. Both situations appear to cause the immune system to mistakenly target acetylcholine receptors, either by exposing immune cells to proteins that resemble the receptor or by disrupting the normal process that teaches immune cells to leave the body’s own tissues alone.
Medications That Worsen MG
Certain widely prescribed drugs can trigger a first episode of MG or push stable disease into crisis. The strongest culprits are specific classes of antibiotics. Fluoroquinolones (such as ciprofloxacin, moxifloxacin, and levofloxacin) directly interfere with nerve-to-muscle signaling at both ends of the junction. In one case series, nine patients who received fluoroquinolones developed significant worsening within as little as 15 minutes to four days after starting the drug. Aminoglycosides and macrolides carry similar risks and are considered contraindicated for people with MG.
Even penicillin-type antibiotics, generally considered safer, aren’t entirely without risk. Six cases of symptom worsening have been documented after amoxicillin therapy, and two relapses linked to ampicillin were confirmed when symptoms returned after the drug was restarted.
Beyond antibiotics, several other drug classes deserve attention:
- Blood pressure medications: Calcium channel blockers like verapamil and nifedipine have caused respiratory failure in patients with severe generalized MG. Beta-blockers carry a lower but possible risk and require close monitoring, especially when first started.
- Tuberculosis drugs: First-line agents including isoniazid and rifamycins can worsen MG through direct effects on the neuromuscular junction and by altering how other medications are processed in the body.
If you have MG and need treatment for any new condition, making sure every prescribing doctor knows about your diagnosis is essential. The list of potentially problematic drugs is long, and alternatives usually exist.
Infections and Respiratory Illness
Infections are one of the most common triggers for MG flares and myasthenic crisis, which is a life-threatening episode of severe weakness affecting breathing muscles. Bacterial pneumonia is a particular concern. In MG patients, bacteria account for more than 90% of pneumonia cases, and drug-resistant strains show up in over 40% of those. This creates a difficult treatment problem, since many of the strongest antibiotics are themselves dangerous for MG.
Viral infections also drive flares. Documented culprits include influenza, COVID-19, respiratory syncytial virus (RSV), adenovirus, varicella-zoster (the virus behind chickenpox and shingles), and cytomegalovirus. The immune activation these infections provoke appears to amplify the autoimmune process already underway. Some antiviral medications used to treat these infections may independently worsen MG through their own effects on the neuromuscular junction or the immune system.
Surgery and Anesthesia
Major surgery poses a real risk of triggering MG symptoms, even in people who didn’t know they had the condition. Among patients undergoing surgery to remove a thymoma who had no prior MG diagnosis, about 8% developed MG after the operation. Those who already had detectable acetylcholine receptor antibodies before surgery were more than five times as likely to develop postoperative MG.
Several surgical factors increase the risk. Open procedures that cause more tissue trauma are associated with higher rates of MG crisis compared to minimally invasive approaches. Greater surgical trauma also raises the chance of postoperative infection, which itself is an independent trigger. Muscle relaxants used during general anesthesia can be particularly dangerous, and anesthesiologists familiar with MG will use them sparingly or avoid them entirely.
Pregnancy and Hormonal Changes
Pregnancy is a well-documented trigger for MG flares. Between 19% and 50% of pregnant women with MG experience a relapse, with the highest-risk periods being the first trimester and the first three months after delivery or pregnancy loss. In one study of 113 patients, 46% relapsed during pregnancy. Of all relapses recorded, 45% occurred in the first trimester and another 45% in the three months following delivery. The second trimester carried the lowest risk, accounting for fewer than 10% of relapses.
The pattern suggests that rapid shifts in immune regulation, rather than a steady hormonal state, are what destabilize MG. During early pregnancy, the immune system undergoes dramatic recalibration to tolerate the developing fetus. After delivery, it shifts back. Both transitions create windows of vulnerability.
Heat and Physical Stress
Many people with MG notice that symptoms flare in hot weather. Heat doesn’t cause new immune damage, but it impairs nerve signal transmission at the already-compromised junction. The effect is temporary but can be significant enough to turn manageable weakness into difficulty swallowing, speaking, or keeping your eyes open. Cooling down with a cold bath or shower can reverse the worsening relatively quickly. Planning outdoor activities for cooler parts of the day and staying well-hydrated helps reduce heat-related flares during summer months.
Physical overexertion and emotional stress also worsen symptoms, likely through a combination of increased body temperature, higher demand on weakened muscles, and stress hormones that influence immune activity.
Electrolyte Imbalances
High magnesium levels can cause neuromuscular blockade even in healthy people, but in MG the margin of safety is much narrower. Magnesium naturally dampens nerve-to-muscle signaling, so elevated levels compound the existing transmission problem. This is clinically relevant because magnesium sulfate is commonly used in hospital settings for conditions like preeclampsia during pregnancy, and its use in someone with MG can precipitate respiratory failure. Low potassium levels can similarly worsen muscle weakness, though specific threshold levels in MG have not been firmly established.
Vaccines and MG Risk
Given that MG is an autoimmune condition, many people worry that vaccines could trigger a flare. A meta-analysis examining influenza and COVID-19 vaccines found no statistically significant increase in MG exacerbation risk. The pooled data showed that vaccination was well tolerated in MG patients, with no meaningful difference in relapse rates between vaccinated and unvaccinated groups. Since respiratory infections like influenza and COVID-19 are themselves proven triggers of MG flares and crisis, the protective benefit of vaccination likely outweighs any theoretical risk.